Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Prostate Cancer | Research

Benefit finding in men affected by prostate cancer prior to and following radical prostatectomy – a cross-sectional study with a stratified sample

Authors: Matthias Jahnen, Patrick Bayer, Valentin H. Meissner, Stefan Schiele, Helga Schulwitz, Jürgen E. Gschwend, Kathleen Herkommer, Andreas Dinkel

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

Benefit finding (BF) - the occurrence of positive life-changes in the aftermath of traumatic live events - has been repeatedly reported in prostate cancer (PCa) survivors, but it remains unclear in which way BF might vary over time. The current study aimed to investigate the extent of BF and associated factors in different phases of the survivorship continuum.

Methods

In this cross-sectional study, men affected by PCa who were either already treated with radical prostatectomy or going to be treated with radical prostatectomy at a large German PCa center were included. These men were stratified into four groups (prior to surgery, up to 12 months after surgery, 2–5 years and ≥ 6–10 years after surgery). BF was assessed using the German version of the 17-item Benefit Finding Scale (BFS). The items are rated on a five-point Likert scale ranging from 1 to 5. A total mean score ≥ 3 was considered as moderate-to-high BF. Associations with clinical and psychological factors were assessed in men presenting before and in those who participated after surgery. Multiple linear regression was applied to identify intendent determinants of BF.

Results

2,298 men affected by PCa (mean age at survey: 69.5,SD = 8.2; median follow-up: 3 years (25th -75th percentile 0.5-7)) were included. 49.6% of men reported moderate-to-high BF. The mean BF score was 2.91 (SD = 0.92). BF reported by men before surgery did not differ significantly from BF reported by men in the years after surgery (p = 0.56). Higher BF prior to and following radical prostatectomy was associated with higher perceived severity of the disease (pre-surgery: ß = 0.188, p = 0.008; post-surgery: ß = 0.161, p = < 0.0001) and higher cancer-related distress (pre-surgery: ß ? 0.155, p = 0.03; post-surgery: ß = 0.089, p < 0.0001). Post radical prostatectomy BF was also associated with biochemical recurrence during follow-up (ß = 0.089, p = 0.001), and higher quality of life (ß = 0.124, p < 0.001).

Conclusions

Many men affected by PCa perceive BF already soon after diagnosis. The subjective perception of threat or severity associated with the diagnosis of PCa is an essential factor for higher levels of BF, probably more important than objective indicators of the severity of the disease. The early onset of BF and the high degree of similarity of BF reported across the different phases of survivorship suggests that BF is, to a large extent, a dispositional personal characteristic and a cognitive strategy of positively coping with cancer.
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRefPubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRefPubMed
2.
go back to reference Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global patterns in prostate Cancer incidence and mortality rates. Eur Urol. 2020;77(1):38–52.CrossRefPubMed Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global patterns in prostate Cancer incidence and mortality rates. Eur Urol. 2020;77(1):38–52.CrossRefPubMed
3.
go back to reference Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–85.CrossRefPubMed Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–85.CrossRefPubMed
5.
go back to reference Chambers SK, Ng SK, Baade P, Aitken JF, Hyde MK, Wittert G, et al. Trajectories of quality of life, life satisfaction, and psychological adjustment after prostate cancer. Psychooncology. 2017;26(10):1576–85.CrossRefPubMedPubMedCentral Chambers SK, Ng SK, Baade P, Aitken JF, Hyde MK, Wittert G, et al. Trajectories of quality of life, life satisfaction, and psychological adjustment after prostate cancer. Psychooncology. 2017;26(10):1576–85.CrossRefPubMedPubMedCentral
6.
go back to reference Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry. Eur Urol. 2015;68(4):600–8.CrossRefPubMed Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry. Eur Urol. 2015;68(4):600–8.CrossRefPubMed
7.
go back to reference Meissner VH, Herkommer K, Marten-Mittag B, Gschwend JE, Dinkel A. Prostate cancer-related anxiety in long-term survivors after radical prostatectomy. J Cancer Surviv. 2017;11(6):800–7.CrossRefPubMed Meissner VH, Herkommer K, Marten-Mittag B, Gschwend JE, Dinkel A. Prostate cancer-related anxiety in long-term survivors after radical prostatectomy. J Cancer Surviv. 2017;11(6):800–7.CrossRefPubMed
8.
go back to reference Helgeson VS, Reynolds KA, Tomich PL. A meta-analytic review of benefit finding and growth. J Consult Clin Psychol. 2006;74(5):797–816.CrossRefPubMed Helgeson VS, Reynolds KA, Tomich PL. A meta-analytic review of benefit finding and growth. J Consult Clin Psychol. 2006;74(5):797–816.CrossRefPubMed
9.
go back to reference Applebaum AJ, Marziliano A, Schofield E, Breitbart W, Rosenfeld B. Measuring positive psychosocial sequelae in patients with advanced cancer. Psychol Trauma. 2021;13(6):703–12.CrossRefPubMed Applebaum AJ, Marziliano A, Schofield E, Breitbart W, Rosenfeld B. Measuring positive psychosocial sequelae in patients with advanced cancer. Psychol Trauma. 2021;13(6):703–12.CrossRefPubMed
10.
go back to reference Casellas-Grau A, Ochoa C, Ruini C. Psychological and clinical correlates of posttraumatic growth in cancer: a systematic and critical review. Psychooncology. 2017;26(12):2007–18.CrossRefPubMed Casellas-Grau A, Ochoa C, Ruini C. Psychological and clinical correlates of posttraumatic growth in cancer: a systematic and critical review. Psychooncology. 2017;26(12):2007–18.CrossRefPubMed
11.
go back to reference Marziliano A, Tuman M, Moyer A. The relationship between post-traumatic stress and post-traumatic growth in cancer patients and survivors: a systematic review and meta-analysis. Psychooncology. 2020;29(4):604–16.CrossRefPubMed Marziliano A, Tuman M, Moyer A. The relationship between post-traumatic stress and post-traumatic growth in cancer patients and survivors: a systematic review and meta-analysis. Psychooncology. 2020;29(4):604–16.CrossRefPubMed
12.
go back to reference Zhu P, Chen C, Liu X, Gu W, Shang X. Factors associated with benefit finding and mental health of patients with cancer: a systematic review. Support Care Cancer. 2022;30(8):6483–96.CrossRefPubMed Zhu P, Chen C, Liu X, Gu W, Shang X. Factors associated with benefit finding and mental health of patients with cancer: a systematic review. Support Care Cancer. 2022;30(8):6483–96.CrossRefPubMed
13.
go back to reference Tedeschi RG, Calhoun LG. Posttraumatic growth: conceptual foundations and empirical evidence. Psychol Inq. 2004;15(1):1–18.CrossRef Tedeschi RG, Calhoun LG. Posttraumatic growth: conceptual foundations and empirical evidence. Psychol Inq. 2004;15(1):1–18.CrossRef
14.
go back to reference Liu Z, Thong MSY, Doege D, Koch-Gallenkamp L, Bertram H, Eberle A, et al. Prevalence of benefit finding and posttraumatic growth in long-term cancer survivors: results from a multi-regional population-based survey in Germany. Br J Cancer. 2021;125(6):877–83.CrossRefPubMedPubMedCentral Liu Z, Thong MSY, Doege D, Koch-Gallenkamp L, Bertram H, Eberle A, et al. Prevalence of benefit finding and posttraumatic growth in long-term cancer survivors: results from a multi-regional population-based survey in Germany. Br J Cancer. 2021;125(6):877–83.CrossRefPubMedPubMedCentral
15.
go back to reference Lassmann I, Dinkel A, Marten-Mittag B, Jahnen M, Schulwitz H, Gschwend JE, et al. Benefit finding in long-term prostate cancer survivors. Support Care Cancer. 2021;29(8):4451–60.CrossRefPubMedPubMedCentral Lassmann I, Dinkel A, Marten-Mittag B, Jahnen M, Schulwitz H, Gschwend JE, et al. Benefit finding in long-term prostate cancer survivors. Support Care Cancer. 2021;29(8):4451–60.CrossRefPubMedPubMedCentral
16.
go back to reference Rankin K, Le D, Sweeny K. Preemptively finding benefit in a breast cancer diagnosis. Psychol Health. 2020;35(5):613–28.CrossRefPubMed Rankin K, Le D, Sweeny K. Preemptively finding benefit in a breast cancer diagnosis. Psychol Health. 2020;35(5):613–28.CrossRefPubMed
17.
go back to reference Brusselaers N, Lagergren J. The Charlson Comorbidity Index in Registry-based Research. Methods Inf Med. 2017;56(5):401–6.CrossRefPubMed Brusselaers N, Lagergren J. The Charlson Comorbidity Index in Registry-based Research. Methods Inf Med. 2017;56(5):401–6.CrossRefPubMed
18.
go back to reference Antoni MH, Lehman JM, Kilbourn KM, Boyers AE, Culver JL, Alferi SM, et al. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol. 2001;20(1):20–32.CrossRefPubMed Antoni MH, Lehman JM, Kilbourn KM, Boyers AE, Culver JL, Alferi SM, et al. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol. 2001;20(1):20–32.CrossRefPubMed
19.
go back to reference Mohamed EN, Böhmer S. Die deutsche Version der Benefit Finding Skala: Ihre psychometrischen Eigenschaften bei Tumorpatienten. Z für Medizinische Psychologie. 2004;13(2):85–91. Mohamed EN, Böhmer S. Die deutsche Version der Benefit Finding Skala: Ihre psychometrischen Eigenschaften bei Tumorpatienten. Z für Medizinische Psychologie. 2004;13(2):85–91.
20.
go back to reference Jansen L, Hoffmeister M, Chang-Claude J, Brenner H, Arndt V. Benefit finding and post-traumatic growth in long-term colorectal cancer survivors: prevalence, determinants, and associations with quality of life. Br J Cancer. 2011;105(8):1158–65.CrossRefPubMedPubMedCentral Jansen L, Hoffmeister M, Chang-Claude J, Brenner H, Arndt V. Benefit finding and post-traumatic growth in long-term colorectal cancer survivors: prevalence, determinants, and associations with quality of life. Br J Cancer. 2011;105(8):1158–65.CrossRefPubMedPubMedCentral
21.
go back to reference Kroenke K, Spitzer RL, Williams JBW. The Patient Health Questionnaire-2 - validity of a two-item depression screener. Med Care. 2003;41(11):1284–92.CrossRefPubMed Kroenke K, Spitzer RL, Williams JBW. The Patient Health Questionnaire-2 - validity of a two-item depression screener. Med Care. 2003;41(11):1284–92.CrossRefPubMed
22.
go back to reference Kroenke K, Spitzer RL, Williams JBW, Monahan PO, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317–25.CrossRefPubMed Kroenke K, Spitzer RL, Williams JBW, Monahan PO, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317–25.CrossRefPubMed
23.
go back to reference Book K, Marten-Mittag B, Henrich G, Dinkel A, Scheddel P, Sehlen S, et al. Distress screening in oncology-evaluation of the Questionnaire on Distress in Cancer Patients-short form (QSC-R10) in a german sample. Psychooncology. 2011;20(3):287–93.CrossRefPubMed Book K, Marten-Mittag B, Henrich G, Dinkel A, Scheddel P, Sehlen S, et al. Distress screening in oncology-evaluation of the Questionnaire on Distress in Cancer Patients-short form (QSC-R10) in a german sample. Psychooncology. 2011;20(3):287–93.CrossRefPubMed
24.
go back to reference Fayers P, Bottomley A. Quality of life research within the EORTC—the EORTC QLQ-C30. Eur J Cancer. 2002;38:125–33.CrossRef Fayers P, Bottomley A. Quality of life research within the EORTC—the EORTC QLQ-C30. Eur J Cancer. 2002;38:125–33.CrossRef
25.
go back to reference Vadaparampil ST, Jacobsen PB, Kash K, Watson IS, Saloup R, Pow-Sang J. Factors predicting prostate specific antigen testing among first-degree relatives of prostate cancer patients. Cancer Epidem Biomar. 2004;13(5):753–8.CrossRef Vadaparampil ST, Jacobsen PB, Kash K, Watson IS, Saloup R, Pow-Sang J. Factors predicting prostate specific antigen testing among first-degree relatives of prostate cancer patients. Cancer Epidem Biomar. 2004;13(5):753–8.CrossRef
26.
go back to reference Taylor SE. Adjustment to threatening events: a theory of cognitive adaptation. Am Psychol. 1983;38(11):1161–73.CrossRef Taylor SE. Adjustment to threatening events: a theory of cognitive adaptation. Am Psychol. 1983;38(11):1161–73.CrossRef
27.
go back to reference McFarland C, Alvaro C. The impact of motivation on temporal comparisons: coping with traumatic events by perceiving personal growth. J Pers Soc Psychol. 2000;79(3):327–43.CrossRefPubMed McFarland C, Alvaro C. The impact of motivation on temporal comparisons: coping with traumatic events by perceiving personal growth. J Pers Soc Psychol. 2000;79(3):327–43.CrossRefPubMed
28.
go back to reference Bi W, Wang H, Yang G, Zhu C. A longitudinal cohort study on benefit finding evolution in chinese women breast cancer survivals. Sci Rep. 2021;11(1):20640.CrossRefPubMedPubMedCentral Bi W, Wang H, Yang G, Zhu C. A longitudinal cohort study on benefit finding evolution in chinese women breast cancer survivals. Sci Rep. 2021;11(1):20640.CrossRefPubMedPubMedCentral
29.
go back to reference Caspari JM, Raque-Bogdan TL, McRae C, Simoneau TL, Ash-Lee S, Hultgren K. Posttraumatic growth after cancer: the role of perceived threat and cognitive processing. J Psychosoc Oncol. 2017;35(5):561–77.CrossRefPubMed Caspari JM, Raque-Bogdan TL, McRae C, Simoneau TL, Ash-Lee S, Hultgren K. Posttraumatic growth after cancer: the role of perceived threat and cognitive processing. J Psychosoc Oncol. 2017;35(5):561–77.CrossRefPubMed
30.
go back to reference Meissner VH, Peter C, Ankerst DP, Schiele S, Gschwend JE, Herkommer K, et al. Prostate cancer-related anxiety among long-term survivors after radical prostatectomy: a longitudinal study. Cancer Med. 2023;12(4):4842–51.CrossRefPubMed Meissner VH, Peter C, Ankerst DP, Schiele S, Gschwend JE, Herkommer K, et al. Prostate cancer-related anxiety among long-term survivors after radical prostatectomy: a longitudinal study. Cancer Med. 2023;12(4):4842–51.CrossRefPubMed
31.
go back to reference Meissner VH, Olze L, Schiele S, Ankerst DP, Jahnen M, Gschwend JE, et al. Fear of cancer recurrence and disease progression in long-term prostate cancer survivors after radical prostatectomy: a longitudinal study. Cancer. 2021;127(22):4287–95.CrossRefPubMed Meissner VH, Olze L, Schiele S, Ankerst DP, Jahnen M, Gschwend JE, et al. Fear of cancer recurrence and disease progression in long-term prostate cancer survivors after radical prostatectomy: a longitudinal study. Cancer. 2021;127(22):4287–95.CrossRefPubMed
32.
go back to reference Jahnen M, Mynzak E, Meissner VH, Schiele S, Schulwitz H, Ankerst DP, et al. Diversity of cancer-related identities in long-term prostate cancer survivors after radical prostatectomy. BMC Cancer. 2021;21(1):1041.CrossRefPubMedPubMedCentral Jahnen M, Mynzak E, Meissner VH, Schiele S, Schulwitz H, Ankerst DP, et al. Diversity of cancer-related identities in long-term prostate cancer survivors after radical prostatectomy. BMC Cancer. 2021;21(1):1041.CrossRefPubMedPubMedCentral
Metadata
Title
Benefit finding in men affected by prostate cancer prior to and following radical prostatectomy – a cross-sectional study with a stratified sample
Authors
Matthias Jahnen
Patrick Bayer
Valentin H. Meissner
Stefan Schiele
Helga Schulwitz
Jürgen E. Gschwend
Kathleen Herkommer
Andreas Dinkel
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11018-7

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine